NTT Data has validated its MaestroAI artificial intelligence (AI) software for the indication of kidney localization and abnormalities detection.
The validation testing was performed in Spain between January 2021 and July 2022 with abdominal CT images, according to the firm. It was conducted in collaboration with the company's local subsidiary, NTT Data Spain, and Fundació Puigvert Hospital in Barcelona.
MaestroAI showed good correlation between its original training dataset from the U.S. and a dataset from Spain, NTT Data said.
